Equities research analysts forecast that CryoPort Inc (NASDAQ:CYRX) will report ($0.07) earnings per share for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for CryoPort’s earnings. The highest EPS estimate is ($0.04) and the lowest is ($0.08). CryoPort posted earnings of ($0.12) per share during the same quarter last year, which indicates a positive year-over-year growth rate of 41.7%. The firm is scheduled to report its next quarterly earnings results on Monday, March 12th.
On average, analysts expect that CryoPort will report full-year earnings of ($0.32) per share for the current fiscal year, with EPS estimates ranging from ($0.34) to ($0.29). For the next year, analysts forecast that the firm will report earnings of ($0.23) per share, with EPS estimates ranging from ($0.26) to ($0.18). Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover CryoPort.
CryoPort (NASDAQ:CYRX) last posted its earnings results on Wednesday, November 1st. The consumer goods maker reported ($0.08) EPS for the quarter, hitting the Zacks’ consensus estimate of ($0.08). CryoPort had a negative return on equity of 46.99% and a negative net margin of 91.28%.
Several institutional investors and hedge funds have recently modified their holdings of CYRX. Northern Trust Corp grew its holdings in shares of CryoPort by 105.0% in the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock worth $109,000 after acquiring an additional 11,358 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of CryoPort in the third quarter worth $118,000. Bank of Montreal Can bought a new stake in shares of CryoPort in the fourth quarter worth $142,000. Wolverine Trading LLC bought a new stake in CryoPort during the third quarter valued at about $230,000. Finally, Granite Investment Partners LLC bought a new stake in CryoPort during the third quarter valued at about $535,000. 18.10% of the stock is owned by institutional investors.
Shares of CryoPort (NASDAQ:CYRX) opened at $8.36 on Friday. CryoPort has a fifty-two week low of $1.96 and a fifty-two week high of $10.40. The company has a market capitalization of $214.54, a price-to-earnings ratio of -16.39 and a beta of 0.99.
COPYRIGHT VIOLATION WARNING: “-$0.07 Earnings Per Share Expected for CryoPort Inc (CYRX) This Quarter” was published by Markets Daily and is owned by of Markets Daily. If you are reading this report on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright law. The correct version of this report can be read at https://www.themarketsdaily.com/2018/01/21/0-07-earnings-per-share-expected-for-cryoport-inc-cyrx-this-quarter.html.
CryoPort Company Profile
Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with MarketBeat.com's FREE daily email newsletter.